ConductScience.org, home

Gene · 406990

MIR208A: microRNA 208a

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MIR208A: microRNA 208a. Genes, record 406990. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/406990

On this page

Gene

Symbol
MIR208A
HGNC
Name
microRNA 208a
HGNC
NCBI Gene ID
406990
NCBI Gene
HGNC ID
HGNC:31585
HGNC
Ensembl
ENSG00000199157
NCBI Gene
Aliases
MIR208, MIRN208, MIRN208A, hsa-mir-208, hsa-mir-208a, miRNA208
NCBI Gene
Type
ncRNA
NCBI Gene

Proteins0

Reviewed human proteins whose Swiss-Prot entry states the gene.

None in this release.

Patents0

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

None in this release.

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants790

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMIR208A papersNewest fiscal year
T32HL007572Research Methods in Pediatric Cardiovascular Disease32025
P30DK036836Diabetes Research Center22025
P30ES013508Center of Excellence in Environmental Toxicology22025
R01DE022971THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION22025
R01DK082659Developmental genes, miRNAs and adipose tissue22025
R01HL076485Engineering Vascularized Cardiac Muscle22025
R01NS017950Precursors of Stroke Incidence and Prognosis22025
R35GM118135Post-transcriptional gene regulation22025
T15LM007033Biomedical Informatics Training Program at Stanford22025
ZIABC010791Effects of genetic polymorphism in MHC, KIR, and related loci on human disease22025

1 to 10 of 790Source NIH's project files

See all 790 nih grants

Papers1,746

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The Role of Circulating Therapeutic MicroRNAs in Pulmonary and Muscular Function in Post-COVID-19 Athletes.Iran J Allergy Asthma Immunol202642825909PubTator, text miningPubMed
MicroRNA expression profile associated with coronary heart disease in patients with resistant arterial hypertension.Front Mol Biosci202642787409PubTator, text miningPubMed
Multi-omics based biomarkers in acute coronary syndrome: Towards precision in cardiovascular medicine.Indian Heart J202642685855PubTator, text miningPubMed
Integrated analysis of MYH6, MYH7, and MYH7B expression and their associated microRNAs in human end-stage heart failure.Front Cardiovasc Med202642630156PubTator, text miningPubMed
Extracellular Vesicles in Cardiovascular Disease: Intercellular Signaling, Liquid Biopsy Biomarkers, and Therapeutic Translation.Circ Res202642594169PubTator, text miningPubMed
Circulating muscle- and inflammation-related microRNAs in breast cancer survivorship: associations with subtype, treatment, timing, and age.Mol Biol Rep202642517980PubTator, text miningPubMed
Bridging the Troponin Blind Window via the miAMI Standard: A Systematic Review and Meta-Analysis of the Circulating MicroRNA-208 Family.Medicina (Kaunas)202642512893PubTator, text miningPubMed
Epigenetic regulation of cardiac physiology and pathophysiology: biological sex matters.J Cardiovasc Aging202642369572PubTator, text miningPubMed
SAFE: a Mix-and-Read Assay for miRNA Detection in Extracellular Vesicles From Unprocessed Plasma Toward Clinical Disease Diagnosis.Small202642339538PubTator, text miningPubMed
The Origin and Application of Cardiomyocyte-Derived Small Extracellular Vesicles: A Systematic Review.Int J Med Sci202642328115PubTator, text miningPubMed

1 to 10 of 1,746

See all 1,746 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/406990

GET https://conductscience.org/api/genes/v1/406990/grants?page=2